PAPAVERINE RENAUDIN 40 mg/ml, solution for injection 10 ampoules of 1 ml
Active ingredients: Papaverine hydrochloride
Commercialized according to BDPM
Solution for injection10 ampoules of 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PAPAVERINE RENAUDIN 40 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2007
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63425566CIP73487385CIP133400934873850Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE PAPAVÉRINEsolution | 40 mg · une ampoule de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.